The latest research from Fore Pharma, ‘US Erectile Dysfunction Market Highlights – 2015’, provides the US Erectile Dysfunction market valuation, competitive landscape, and Erectile Dysfunction products sales in the US. The research includes US Erectile Dysfunction market size estimates for 2014, Erectile Dysfunction products market share, and Erectile Dysfunction products sales estimates. This research helps executives track competitor product sales and market share in the US Erectile Dysfunction market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US Erectile Dysfunction market.
Scope of the Research:
Erectile Dysfunction as defined in EphMRA Anatomical Therapeutic Chemical classification code G4E
Marketed Products: Identify Erectile Dysfunction products marketed including brand name, molecule name, and company
Sales Estimates: Find out estimates for the US Erectile Dysfunction market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate sales valuation of products and the market
Competitive Landscape: You will know the market share of leading Erectile Dysfunction products in 2014 and how they have changed from 2011
Pipeline: Find out key Erectile Dysfunction products in clinical trial phase 3 and phase 2. Coverage includes molecule, mechanism of action, and the company developing the product